rs747124369
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_001184880.2(PCDH19):c.2191G>A(p.Gly731Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000207 in 1,205,690 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001184880.2 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 9Inheritance: XL, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- X-linked complex neurodevelopmental disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- Dravet syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PCDH19 | NM_001184880.2 | c.2191G>A | p.Gly731Arg | missense_variant | Exon 2 of 6 | ENST00000373034.8 | NP_001171809.1 | |
| PCDH19 | NM_001105243.2 | c.2148-770G>A | intron_variant | Intron 1 of 4 | NP_001098713.1 | |||
| PCDH19 | NM_020766.3 | c.2148-770G>A | intron_variant | Intron 1 of 4 | NP_065817.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PCDH19 | ENST00000373034.8 | c.2191G>A | p.Gly731Arg | missense_variant | Exon 2 of 6 | 1 | NM_001184880.2 | ENSP00000362125.4 | ||
| PCDH19 | ENST00000255531.8 | c.2148-770G>A | intron_variant | Intron 1 of 4 | 1 | ENSP00000255531.7 | ||||
| PCDH19 | ENST00000420881.6 | c.2148-770G>A | intron_variant | Intron 1 of 4 | 1 | ENSP00000400327.2 | ||||
| PCDH19 | ENST00000636150.1 | c.66-1046G>A | intron_variant | Intron 1 of 2 | 5 | ENSP00000490463.1 |
Frequencies
GnomAD3 genomes AF: 0.000107 AC: 12AN: 112342Hom.: 0 Cov.: 24 show subpopulations
GnomAD2 exomes AF: 0.0000177 AC: 3AN: 169636 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000119 AC: 13AN: 1093348Hom.: 0 Cov.: 30 AF XY: 0.00000556 AC XY: 2AN XY: 359516 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000107 AC: 12AN: 112342Hom.: 0 Cov.: 24 AF XY: 0.000174 AC XY: 6AN XY: 34528 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 9 Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 731 of the PCDH19 protein (p.Gly731Arg). This variant is present in population databases (rs747124369, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with PCDH19-related conditions. ClinVar contains an entry for this variant (Variation ID: 533846). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PCDH19 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at